Optimization of Apta-Sensing Platform for Detection of Prostate Cancer Marker PCA3
Abstract
:1. Introduction
2. Results and Discussion
2.1. Electrochemical Detection of PCA3 Using Aptamer Labeled with Methylene Blue
2.2. Optical Detection of PCA3 with Non-Labeled Aptamer Using the Method of Total Internal Reflection Ellipsometry (TIRE)
2.3. XPX Study
3. Materials and Methods
3.1. Aptamers and Target Analyte
3.2. Immobilization of Aptamers, Electrochemical and Optical Sensor Fabrication
3.3. Cyclic Voltammogram Measurements
3.4. Spectroscopic Ellipsometry Measurements
3.5. X-ray Photoelectron Spectroscopy (XPS) Measurements
4. Conclusions
Supplementary Materials
Author Contributions
Funding
Data Availability Statement
Conflicts of Interest
References
- Ferlay, J.; Soerjomataram, I.; Dikshit, R.; Eser, S.; Mathers, C.; Rebelo, M.; Parkin, D.M.; Forman, D.; Bray, F. Cancer Incidence and Mortality Worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Int. J. Cancer 2015, 136, E359–E386. [Google Scholar] [CrossRef] [PubMed]
- Adhyam, M.; Gupta, A.K. A Review on the Clinical Utility of PSA in Cancer Prostate. Indian J. Surg. Oncol. 2012, 3, 120–129. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Landers, K.A.; Burger, M.J.; Tebay, M.A.; Purdie, D.M.; Scells, B.; Samaratunga, H.; Lavin, M.F.; Gardiner, R.A. Use of multiple biomarkers for a molecular diagnosis of prostate cancer. Int. J. Cancer 2005, 114, 950–956. [Google Scholar] [CrossRef] [PubMed]
- Bussemakers, M.J.G.; Van Bokhoven, A.; Verhaegh, G.W.; Smit, F.P.; Karthaus, H.F.; Schalken, J.A.; Debruyne, F.M.J.; Ru, N.; Isaacs, W.B. DD3: A new prostate-specific gene, highly overexpressed in prostate cancer. Cancer Res. 1999, 59, 5975–5979. Available online: https://cancerres.aacrjournals.org/content/59/23/5975 (accessed on 20 October 2021).
- Groskopf, J.; Aubin, S.M.; Deras, I.L.; Blase, A.; Bodrug, S.; Clark, C.; Brentano, S.; Mathis, J.; Pham, J.; Meyer, T.; et al. APTIMA PCA3 Molecular Urine Test: Development of a Method to Aid in the Diagnosis of Prostate Cancer. Clin. Chem. 2006, 52, 1089–1095. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Deras, I.L.; Aubin, S.M.; Blase, A.; Day, J.R.; Koo, S.; Partin, A.W.; Ellis, W.J.; Marks, L.S.; Fradet, Y.; Rittenhouse, H.; et al. PCA3: A Molecular Urine Assay for Predicting Prostate Biopsy Outcome. J. Urol. 2008, 179, 1587–1592. [Google Scholar] [CrossRef] [PubMed]
- Haese, A.; de la Taille, A.; van Poppel, H.; Marberger, M.; Stenzl, A.; Mulders, P.F.A.; Huland, H.; Abbou, C.-C.; Remzi, M.; Tinzl, M.; et al. Clinical Utility of the PCA3 Urine Assay in European Men Scheduled for Repeat Biopsy. Eur. Urol. 2008, 54, 1081–1088. [Google Scholar] [CrossRef] [Green Version]
- Nakanishi, H.; Groskopf, J.; Fritsche, H.A.; Bhadkamkar, V.; Blase, A.; Kumar, S.V.; Davis, J.W.; Troncoso, P.; Rittenhouse, H.; Babaian, R.J. PCA3 Molecular Urine Assay Correlates with Prostate Cancer Tumor Volume: Implication in Selecting Candidates for Active Surveillance. J. Urol. 2008, 179, 1804–1810. [Google Scholar] [CrossRef]
- Malavaud, B.; Cussenot, O.; Mottet, N.; Rozet, F.; Ruffion, A.; Smets, L.; Stoevelaar, H. Impact of adoption of a decision algorithm including PCA3 for repeat biopsy on the costs for prostate cancer diagnosis in France. J. Med. Econ. 2013, 16, 358–363. [Google Scholar] [CrossRef]
- Rittenhouse, H.; Blase, A.; Shamel, B.; Schalken, J.; Groskopf, J. The Long and Winding Road to FDA Approval of a Novel Prostate Cancer Test: Our Story. Clin. Chem. 2013, 59, 32–34. [Google Scholar] [CrossRef] [Green Version]
- Nicholson, A.; Mahon, J.; Boland, A.; Beale, S.; Dwan, K.; Fleeman, N.; Hockenhull, J.; Dundar, Y. The clinical effectiveness and cost-effectiveness of the PROGENSA® prostate cancer antigen 3 assay and the Prostate Health Index in the diagnosis of prostate cancer: A systematic review and economic evaluation. Health Technol. Assess. 2015, 19, 1–192. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Pasinszki, T.; Krebsz, M.; Tung, T.T.; Losic, D. Carbon Nanomaterial Based Biosensors for Non-Invasive Detection of Cancer and Disease Biomarkers for Clinical Diagnosis. Sensors 2017, 17, 1919. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Topkaya, S.N.; Azimzadeh, M.; Ozsoz, M. Electrochemical Biosensors for Cancer Biomarkers Detection: Recent Advances and Challenges. Electroanalysis 2016, 28, 1402–1419. [Google Scholar] [CrossRef]
- Li, G.; Xia, Y.; Tian, Y.; Wu, Y.; Liu, J.; He, Q.; Chen, D. Review—Recent Developments on Graphene-Based Electrochemical Sensors toward Nitrite. J. Electrochem. Soc. 2019, 166, B881–B895. [Google Scholar] [CrossRef]
- Díaz-Fernández, A.; Lorenzo-Gómez, R.; Miranda-Castro, R.; De-Los-Santos-Álvarez, N.; Lobo-Castañón, M.J. Electrochemical aptasensors for cancer diagnosis in biological fluids—A review. Anal. Chim. Acta 2020, 1124, 1–19. [Google Scholar] [CrossRef]
- Vilela, P.; El-Sagheer, A.; Millar, T.M.; Brown, T.; Muskens, O.L.; Kanaras, A.G. Graphene Oxide-Upconversion Nanoparticle Based Optical Sensors for Targeted Detection of mRNA Biomarkers Present in Alzheimer’s Disease and Prostate Cancer. ACS Sens. 2017, 2, 52–56. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Soares, J.C.; Soares, A.C.; Rodrigues, V.C.; Melendez, M.E.; Santos, A.C.; Faria, E.F.; Reis, R.M.; Carvalho, A.L.; Oliveira, O.N., Jr. Detection of the Prostate Cancer Biomarker PCA3 with Electrochemical and Impedance-Based Biosensors. ACS Appl. Mater. Interfaces 2019, 11, 46645–46650. [Google Scholar] [CrossRef] [PubMed]
- Rodrigues, V.C.; Soares, J.C.; Soares, A.C.; Braz, D.C.; Melendez, M.E.; Ribas, L.C.; Scabini, L.F.; Bruno, O.M.; Carvalho, A.L.; Reis, R.M.; et al. Electrochemical and optical detection and machine learning applied to images of genosensors for diagnosis of prostate cancer with the biomarker PCA3. Talanta 2020, 222, 121444. [Google Scholar] [CrossRef]
- Hamula, C.L.A.; Zhang, H.; Li, F.; Wang, Z.; Le, X.C.; Li, X.-F. Selection and analytical applications of aptamers binding microbial pathogens. TrAC Trends Anal. Chem. 2011, 30, 1587–1597. [Google Scholar] [CrossRef]
- Zhang, Y.; Lai, B.S.; Juhas, M. Recent Advances in Aptamer Discovery and Applications. Molecules 2019, 24, 941. [Google Scholar] [CrossRef] [Green Version]
- Jarczewska, M.; Górski, Ł.; Malinowska, E. Electrochemical aptamer-based biosensors as potential tools for clinical diagnostics. Anal. Methods 2016, 8, 3861–3877. [Google Scholar] [CrossRef] [Green Version]
- Park, Y.; Hong, M.-S.; Lee, W.-H.; Kim, J.-G.; Kim, K. Highly Sensitive Electrochemical Aptasensor for Detecting the VEGF165 Tumor Marker with PANI/CNT Nanocomposites. Biosensors 2021, 11, 114. [Google Scholar] [CrossRef] [PubMed]
- Zhang, G.; Liu, Z.; Wang, L.; Guo, Y. Electrochemical Aptasensor for Myoglobin-Specific Recognition Based on Porphyrin Functionalized Graphene-Conjugated Gold Nanocomposites. Sensors 2016, 16, 1803. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Oo, S.-L.; Venkatesh, S.; Karthikeyan, V.; Arava, C.M.; Pathikonda, S.; Yu, P.K.N.; Lau, T.C.K.; Chen, X.; Roy, V.A.L. Highly Sensitive and Cost-Effective Portable Sensor for Early Gastric Carcinoma Diagnosis. Sensors 2021, 21, 2639. [Google Scholar] [CrossRef] [PubMed]
- Kong, W.; Qu, F.; Lu, L. A photoelectrochemical aptasensor based on p-n heterojunction CdS-Cu2O nanorod arrays with enhanced photocurrent for the detection of prostate-specific antigen. Anal. Bioanal. Chem. 2020, 412, 841–848. [Google Scholar] [CrossRef]
- Nabok, A.; Abu-Ali, H.; Takita, S.; Smith, D.P. Electrochemical Detection of Prostate Cancer Biomarker PCA3 Using Specific RNA-Based Aptamer Labelled with Ferrocene. Chemosensors 2021, 9, 59. [Google Scholar] [CrossRef]
- Pan, D.; Zuo, X.; Wan, Y.; Wang, L.; Zhang, J.; Song, S.; Fan, C. Electrochemical Interrogation of Interactions between Surface-Confined DNA and Methylene Blue. Sensors 2007, 7, 2671–2680. [Google Scholar] [CrossRef] [Green Version]
- Abu-Ali, H.; Ozkaya, C.; Davis, F.; Walch, N.; Nabok, A. Electrochemical Aptasensor for Detection of Dopamine. Chemosensors 2020, 8, 28. [Google Scholar] [CrossRef] [Green Version]
- Castner, D.G.; Hinds, K.; Grainger, D.W. X-ray Photoelectron Spectroscopy Sulfur 2p Study of Organic Thiol and Disulfide Binding Interactions with Gold Surfaces. Langmuir 1996, 12, 5083–5086. [Google Scholar] [CrossRef]
- Marangoni, K.; Neves, A.F.; Rocha, R.M.; Faria, P.R.; Alves, P.T.; Souza, A.G.; Fujimura, P.T.; Santos, F.A.A.; Araújo, T.G.; Ward, L.S.; et al. Prostate-specific RNA aptamer: Promising nucleic acid antibody-like cancer detection. Sci. Rep. 2015, 5, 12090. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- X-ray Photoelectron Spectrometry Popular Elements—Advancing Materials. Available online: https://www.thermofisher.com/blog/materials/x-ray-photoelectron-spectrometry-commonly-referenced-elements/ (accessed on 23 November 2021).
- Arwin, H.; Poksinski, M.; Johansen, K. Total internal reflection ellipsometry: Principles and applications. Appl. Opt. 2004, 43, 3028–3036. [Google Scholar] [CrossRef]
- Nabok, A.; Tsargorodskaya, A.; Hassan, A.K.; Starodub, N.F. Total internal reflection ellipsometry and SPR detection of low molecular weight environmental toxins. Appl. Surf. Sci. 2005, 246, 381–386. [Google Scholar] [CrossRef]
- Nabok, A.; Tsargorodskaya, A.; Holloway, A.; Starodub, N.F.; Gojster, O. Registration of T-2 mycotoxin with total internal reflection ellipsometry and QCM impedance methods. Biosens. Bioelectron. 2007, 22, 885–890. [Google Scholar] [CrossRef]
- Nabok, A.; Tsargorodskaya, A. The method of total internal reflection ellipsometry for thin film characterisation and sensing. Thin Solid Films 2008, 516, 8993–9001. [Google Scholar] [CrossRef]
- Nabok, A.; Tsargorodskaya, A.; Mustafa, M.; Szekacs, A.; Székács, I.; Starodub, N. Detection of low molecular weight toxins using optical phase detection techniques. Procedia Chem. 2009, 1, 1491–1494. [Google Scholar] [CrossRef] [Green Version]
- Al Rubaye, A.; Nabok, A.; Catanante, G.; Marty, J.-L.; Takacs, E.; Szekacs, A. Detection of ochratoxin A in aptamer assay using total internal reflection ellipsometry. Sens. Actuators B Chem. 2018, 263, 248–251. [Google Scholar] [CrossRef] [Green Version]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Takita, S.; Nabok, A.; Lishchuk, A.; Smith, D. Optimization of Apta-Sensing Platform for Detection of Prostate Cancer Marker PCA3. Int. J. Mol. Sci. 2021, 22, 12701. https://doi.org/10.3390/ijms222312701
Takita S, Nabok A, Lishchuk A, Smith D. Optimization of Apta-Sensing Platform for Detection of Prostate Cancer Marker PCA3. International Journal of Molecular Sciences. 2021; 22(23):12701. https://doi.org/10.3390/ijms222312701
Chicago/Turabian StyleTakita, Sarra, Alexei Nabok, Anna Lishchuk, and David Smith. 2021. "Optimization of Apta-Sensing Platform for Detection of Prostate Cancer Marker PCA3" International Journal of Molecular Sciences 22, no. 23: 12701. https://doi.org/10.3390/ijms222312701
APA StyleTakita, S., Nabok, A., Lishchuk, A., & Smith, D. (2021). Optimization of Apta-Sensing Platform for Detection of Prostate Cancer Marker PCA3. International Journal of Molecular Sciences, 22(23), 12701. https://doi.org/10.3390/ijms222312701